Lee Memorial Health System has earned its STAR Program Certification from the Massachusetts-based Oncology Rehab Partners, leading experts in the field of survivorship care.
Lee Memorial Health System is leading the way by offering excellent cancer rehabilitation services to its patients by becoming STAR Certified.
STAR Certification uniquely qualifies hospitals and cancer centers like Lee Memorial to offer premium oncology rehabilitation services to survivors who suffer from debilitating side effects caused by cancer or its treatments.
To receive certification, Lee Memorial executed the program, a conventional medicine and evidence-based standardized model of oncology rehab service delivery, successfully implementing the program's evaluation and treatment protocols and rehabilitation training. These services are covered by health insurance providers and offered to patients by a knowledgeable and sensitive medical staff specially trained to work with newly diagnosed cancer patients, those going through treatments, and survivors of all forms of cancer. They will have the tools needed to quickly and effectively implement an exceptional survivorship care plan.
Specialty clinicians from a pool of disciplines including physicians, physical and occupational therapists, speech and language pathologists, oncology dieticians, nurse navigators, nurses, nurse practitioners, and social workers work together on a personalized rehab plan for each patient to increase strength and energy, alleviate pain, and improve daily function and quality of life.
"The STAR Program is the gold standard in cancer rehabilitation care," says Sharon MacDonald, vice president of oncology services for Lee Memorial Health System. "This certification demonstrates our commitment to developing best-practice oncology rehabilitation services that will improve the quality of care and outcomes for our patients."
Dr. Larry Antonucci, COO, presented the STAR Certificate to MacDonald, and Dr. Jimmy Orr, Regional Cancer Center's Medical Director.
STAR clinicians anticipate seeing patients in mid-February.